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d T-bet and p40 are dispensable for entry of CD4 T cells into the
lungs in Mtb infection
d T-bet and p40 drive production of non-protective
intravascular CX3CR1+ Th1 cells
d T-bet inhibits the generation of Trm-like CD69+CD103+ Th17
cells in Mtb infection
d Th1-derived IFN-g negatively regulates the accumulation of
iv+CX3CR1+ Th1 cells
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Sallin et al. show that IL-12/23p40 and
T-bet have a detrimental impact on the
quality of some Th1 cells in TB. Although
required for IFN-g production and host
survival, these factors are dispensable for
migration of T cells into the lung and drive
the differentiation of non-protective
intravascular CX3CR1+KLRG1+ Th1 cells.
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Recent data indicate that the differentiation state
of Th1 cells determines their protective capacity
against tuberculosis. Therefore, we examined the
role of Th1-polarizing factors in the generation of
protective and non-protective subsets of Mtb-spe-
cific Th1 cells. We find that IL-12/23p40 promotes
Th1 cell expansion and maturation beyond the
CD73+CXCR3+T-betdim stage, and T-bet prevents
deviation of Th1 cells into Th17 cells. Nevertheless,
IL- 12/23p40 and T-bet are also essential for the
production of a prominent subset of intravascular
CX3CR1+KLRG1+ Th1 cells that persists poorly
and can neither migrate into the lung parenchyma
nor control Mtb growth. Furthermore, T-bet sup-
presses development of CD69+CD103+ tissue resi-
dent phenotype effectors in lung. In contrast,
Th1-cell-derived IFN-g inhibits the accumulation of
intravascular CX3CR1+KLRG1+ Th1 cells. Thus,
although IL-12 and T-bet are essential host survival
factors, they simultaneously oppose lung CD4
T cell responses at several levels, demonstrating
the dual nature of Th1 polarization in tuberculosis.
INTRODUCTION
Mycobacterium tuberculosis (Mtb) is a leading cause of death
due to infectious disease. The development of new highly effec-
tive vaccination strategies would have a dramatic benefit on
global public health; however, this is an enormous challenge
for the field. For example, a well-studied vaccine candidate,
modified vaccinia Ankara (MVA) expressing the Mtb protein
Ag85A, has been shown to induce strong and durable CD4
T cell responses in humans but offer no protection against tuber-
culosis (Tameris et al., 2013). It is still not clear why this particular
platform did not protect against tuberculosis (TB), but the
rational development of new vaccines forMtb infection has argu-
ably been made more difficult by a lack of information on the
properties of protective CD4 T cells. Apart from the requirement
for some interferon g (IFN-g) production, not a lot is known about
what type of T helper cell is most capable of mediating control of
Mtb infection.
The ability of CD4 T cells to suppress the growth of Mtb re-
quires the direct interaction with infected macrophages in the
lung, so the ability to migrate into the Mtb-infected lung is likely
a key feature of protective T cells (Srivastava and Ernst, 2013).
Recent studies of Mtb-specific CD4 T cells have indicated that
the differentiation state of the Th1 cells has a profound effect
on their ability to migrate into the lung and therefore mediate
control ofMtb infection. Our group showed that T-betdimCXCR3+
CD4 T cells are able to rapidly migrate into Mtb-infected lungs
and mediate potent control of the infection, while a subset of
CD4 T cells resembling terminal effectors (T-betbrightKLRG1+)
and co-expressing CX3CR1 poorly migrates into the lungs,
accumulating in the lung-associated blood vasculature instead,
and contributes very little to control of pulmonary infection (Sakai
et al., 2014). At the peak of the clonal burst, this intravascular
non-protective CX3CR1+KLRG1+ CD4 T cells can comprise
approximately half of the total antigen-specific response, at least
in C57BL/6 mice. Preclinical vaccination studies have also found
that vaccine candidates preferentially generating KLRG1– CD4
T cells tend to be more protective against virulent challenge (Lin-
denstrøm et al., 2013; Woodworth et al., 2014, 2016). Indeed,
there are increasing data that suggest CD4 T cells that are less
polarized toward the Th1 lineage are more protective against
Mtb infection, while highly differentiated Th1 cells, despite their
enhanced effector functions, are less beneficial to control of
Mtb infection. Therefore, it is important to understand the factors
that regulate the generation of protective versus non-protective
T cells. In this regard, it has recently been shown that the popu-
lation of lung-homing cells in Mtb infection is dependent on
BCL6,maintained by inducible T cell costimulator (ICOS), and re-
tained in the lung at least partly through CXCR5, again indicating
that protective T cells are in a less differentiated or more mem-
ory-like state (Moguche et al., 2015). It has also been shown
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that interleukin-27R (IL-27R) on CD4 T cells drives the generation
of KLRG1+ CD4 T cells and impairs control of the infection (Tor-
rado et al., 2015).
The overall strength of stimulation through the T cell receptor
(TCR), co-stimulatory pathways, and innate inflammatory cyto-
kines determines the extent of T cell differentiation, where
greater amounts of stimulation result in the progression of higher
proportions of responding T cells into the terminally differenti-
ated phenotype (Kaech and Cui, 2012). In particular, the forma-
tion of terminal effector cells is largely dependent on the IL-12/
T-bet axis, which drives their generation in a dose-dependent
manner (Joshi et al., 2007). In the context of host resistance to
Mtb infection, IL-12 and T-bet are well known to be critical
host-protective molecules. Humans and mice deficient in the
IL-12 pathway are extremely susceptible to mycobacterial infec-
tions (O’Garra et al., 2013), and T-bet/ mice (Sullivan et al.,
2005) likewise cannot control Mtb growth. The requirements
for these molecules in host resistance are likely due to the
role of this pathway in the induction of IFN-g-expressing CD4
T cells that contribute to host protection (Green et al., 2013;
Sakai et al., 2016).
This raises the possibility that, while IL-12 and T-bet play ama-
jor role in host resistance against Mtb infection, at higher levels
they may also have an unappreciated detrimental impact on
T cell differentiation by promoting the polarization of CD4
T cells into a terminal effector-like state whereby they lose the
ability to migrate into the lung parenchyma. Consistent with
this hypothesis, it was recently shown that T-bet+/ mice display
a slightly enhanced resistance to Mtb infection compared
to wild-type (WT) mice rather than the extreme susceptibility
seen in the T-bet/ animals (Sullivan et al., 2005; Torrado
et al., 2015). Indeed, here we show that the relatively high TCR
signals IL-12/23p40 and T-bet have unexpected negative effects
on the protective capacity of Mtb-specific CD4 T cells by driving
the development of a large population of terminal effector-like
CX3CR1+KLRG1+ Th1 cells that cannot contribute to control of
pulmonary Mtb infection.
RESULTS
CD4 T Cell Differentiation Status Determines Protective
Capacity against Mtb Infection
We have previously shown that the ability to migrate into the lung
parenchyma and protect against Mtb infection correlates with
the lack of KLRG1 expression onMtb-specific CD4 T cells (Sakai
et al., 2014). To better characterize the migration of Mtb-specific
CD4 T cells into the lungs and development of intravascular
KLRG1+ CD4 T cells, we utilized the magnetic-bead-based
tetramer pull-down approach along with intravascular staining
to track the I-AbESAT-64–17-specific CD4 T cell response. Ag-
specific T cells were first observed in the mediastinal lymph
nodes at day 14 post-infection and were exclusively KLRG1–
(Figure 1A). The response dramatically increased by day 18
post-infection, at which time I-AbESAT-64–17-specific CD4
T cells were found in the mediastinal lymph node, peripheral
blood, lung parenchyma (intravascular [iv]–), and lung vascula-
ture (iv+) (Figure 1A). KLRG1 expression continued to increase
after day 18, with the highest expression on iv+ CD4 T cells at
day 28 post-infection, the approximate peak of clonal expansion
(Figure 1B). We next examined the expression of T-bet, CXCR3,
CX3CR1, and CD73 on the I-AbESAT-64–17 CD4 T cells in
the lung after subsetting based on lung localization and
KLRG1 expression: iv+KLRG1, ivKLRG1, ivKLRG1+, and
iv+KLRG1+. The iv+KLRG1+ cells had the highest amounts of
T-bet and CX3CR1 and the lowest frequency of CXCR3+ and
CD73+ (Figure 1C), whereas the iv–KLRG1– cells had the lowest
T-bet and CX3CR1 expression and the highest amounts of
CXCR3+ and CD73 expression (Figure 1C). Interestingly,
iv+KLRG1+ and iv–KLRG1+ cells differentially expressed each
of thesemarkers, indicating that even among KLRG1-expressing
T cells the intravascular cells display a more differentiated
phenotype compared to their parenchymal counterparts. These
data suggest that iv+KLRG1+ CD4 T cells may represent a pop-
ulation of terminally differentiated cells.
We next examined the lineage relationship between these
subsets of T cells. The four populations of effector CD4 T cells
were individually fluorescence-activated cell sorted (FACS)
from the lungs at day 28 post-infection and adoptively trans-
ferred into infection-matched, congenically disparate recipients.
Two weeks after transfer, the expression of KLRG1 on the donor
cells was measured. The iv+KLRG1– and iv–KLRG1– cells both
gave rise to KLRG1+ cells (Figure 1D). Interestingly, KLRG1+ cells
isolated from the parenchyma gave rise to a small population of
KLRG1– cells, indicating that some parenchymal KLRG1+ CD4
T cells may convert to KLRG1– cells. In contrast, KLRG1+ cells
purified from the vasculature remained uniformly high for
KLRG1 expression (Figure 1D). These data are consistent with
a previous report indicating that KLRG1– CD4 T cells give rise
to KLRG1+ CD4 T cells during Mtb infection (Reiley et. al.,
2010). Overall, these data indicate that intravascular KLRG1+
display the least plasticity, supporting the hypothesis that Mtb-
specific KLRG1+ CD4 T cells in the lung blood vasculature likely
represent a population of terminally differentiated effector cells.
We have previously demonstrated that bulk iv+ effector CD4
T cells sorted with FACS poorly migrate into the lungs onMtb-in-
fected mice (Sakai et al., 2014), and we sought to validate these
findings using T cells that were sorted with FACS based on iv
stain as well as KLRG1 status. Each of the four subsets was
individually FACS purified and then transferred into infection-
matched, congenically disparate recipients, and migration into
the lung parenchyma was measured 1.5 days later. As shown
before, parenchymal effector cells migrated rapidly into the
lung, although iv–KLRG1– donor CD4 T cells migrated better
compared to iv–KLRG1+ donors (Figure 1E). The iv+KLRG1–
donor CD4 T cells also efficiently migrated into the lung. In
contrast, the iv+KLRG1+ CD4 T cells migrated poorly, with only
about 5%–10%entering the lung parenchyma (Figure 1E). These
data rule out potential artifacts that could have been introduced
in our previous results due to interconversion between pheno-
types and confirm that CD4 T cell differentiation state is tightly
linked to migratory ability.
We also have previously shown that bulk iv+ and iv– CD4 T cells
FACS purified from the lungs of Mtb-infected mice greatly differ
in their ability to transfer protection to Mtb-infected T cell/
mice, with only small amounts of protection mediated by the
intravascular cells versus robust protection mediated by the
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parenchymal cells (Sakai et al., 2014). To validate and extend
these findings, we refined our approach by utilizing Foxp3-GFP
reporter mice so that Tregs could be excluded and further frac-
tionating the CD44highFoxp3– effector CD4 T cells based on both
iv status as well as KLRG1 expression. Each of the resulting four
subsets of highly purified effector CD4 T cells were transferred
into TCRa/ hosts that had been infected with Mtb 1 week pre-
viously. On day 28 post-infection, the number of donor CD4
T cells and bacterial loads were measured in the lungs of
the recipient mice (Figures 1F and 1G). Interestingly, both the
KLRG1– and KLRG1+ parenchymal subsets as well as the
KLRG1– intravascular cells, all of which displayed lung-homing
ability, expanded in the lungs after transfer and reduced bacterial
loads to similar levels. In contrast, the intravascular KLRG1+
effector CD4 T cells, which did not migrate into the lungs in our
short-term assay, were recovered at 10- to 100-fold lower
numbers compared to the other subsets and displayed no ability
to reduce bacterial loads (Figures 1F and 1G). These data are
consistent with a recent report in T. gondii-infected mice that
found parasite-specific KLRG1+CXCR3– CD8 T cells failed to
proliferate or convert to other phenotypes after transfer into
infection-matched recipients (Chu et al., 2016). These data
also confirm our previous findings and formally show that
CX3CR1+KLRG1+ CD4 T cells in the lung blood vasculature
bear markers of terminally differentiated effectors and due to
their poor proliferative and migratory ability do not provide pro-
tection against pulmonary Mtb infection.
Intraclonal Competition for Antigen after Priming Limits
Terminal Differentiation and Promotes Th17 Generation
We next examined the role that the amount of antigen-recogni-
tion plays in driving the generation of the terminal effectors. To
do so, we first polarized ESAT-6-specific TCR-Tg (C7) CD4
T cells in vitro with increasing concentrations of IL-12 and IL-2.
This resulted in six different effector cell populations with a
gradient of T-bet expression levels (Figure 2A). Each of these
six different populations was then transferred into Mtb-infected
WT mice at three different doses of TCR Tg-polarized effector
A
D E F G
B C
Figure 1. Host Protective Mtb-Specific CD4 T Cells Differentiate into Intravascular Non-protective Terminal Effectors
(A and B) Kinetic analysis of the I-AbESAT-64–17 tetramer-specific response in the blood, mediastinal lymph node (MLN), iv
–, and iv+ compartments of
the lung using the major histocompatibility complex class II (MHC class II) tetramer pull-down assay. (A) Representative FACS plots shown are gated on
I-AbESAT-64–17
+CD4+ cells. (B) Summary graphs of the I-AbESAT-64–17
+CD4+KLRG1+ cells in the blood, MLN, iv– lung, and iv+ lung. The blood and lymph node
are pooled from three to four mice at each time point.
(C) The expression of indicated markers on the iv+KLRG1–, iv–KLRG1–, iv–KLRG1–, and iv+KLRG1+ lung cells. Gray histogram is the expression on naive CD4
T cells.
(D–G) CD44hiFoxp3–CD4+ cells were sorted from D28PI (post-infection) Foxp3-GFP reporter mice into four populations: iv+KLRG1–, iv–KLRG1–, iv–KLRG1+, or
iv+KLRG1+ cells. (D) Sorted cells were transferred into congenic mice on D28PI and lungs harvested on D42PI. The frequency of KLRG1+ donor cells recovered.
Each point is an independent experiment with FACS plots concatenated from two to five mice. *p % 0.05, **p % 0.01, ns, paired t test.
(E) Sorted cells were transferred into congenicmice on D28PI and lungs harvested on D30PI. The frequency of iv– donor cells recovered. Data are pooled from two
experiments. *p % 0.05, ****p % 0.0001, one-way ANOVA, with Tukey’s multiple comparisons test.
(F and G) Sorted cells were transferred into TCRa/ mice on day 7PI and harvested on D28PI. (F) Log10-transformed total donor cell numbers recovered and
(G) log10-transformed CFU counts from the lung of TCRa
/ recipient mice are shown. The whiskers represent the minimum and maximum values, and the lines
represent the geometric mean. Data are pooled from two experiments. *p % 0.05, **p % 0.01, one-way ANOVA, with Tukey’s multiple comparisons test.
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cells, 53 104, 53 105, and 53 106 (Figure 2A), and the cells were
analyzed 10 days later (day 16 post-infection). Varying the
amount of IL-12 and IL-2 in the initial culture allowed us to
examine the impact the degree of initial Th1 polarization has
on the subsequent generation of terminal effectors. By also vary-
ing the number of cells injected to increase intraclonal competi-
tion, we could examine the impact the strength of TCR stimula-
tion has on the generation of terminal effectors.
The frequency of donor C7 cells among total CD4 T cells
increased with the number transferred, but there was no correla-
tion between the expansion of the donor cells and the initial Th1-
polarizing conditions (Figure 2B). Strikingly, the number of donor
cells injected had a dramatic, dose-dependent effect on the
development of KLRG1+T-betbright terminal effectors, while the
initial in vitro Th1-polarizing conditions had no detectable effect
(Figures 2C and 2D). In recipient mice receiving the lowest dose
of 5 3 104 T cells, 50% of the donor C7 cells were terminal ef-
fectors, whereas in mice receiving the highest dose of 5 3 106
cells that decreased to 5%. We also noted that the T-bet geo-






Figure 2. Clonal Competition for Antigen Inhibits the Generation of Terminally Differentiated Th1 Cells and Facilitates Development of Th17
Cells during Mtb Infection
(A) Schematic of experimental setup. The increasing concentrations of IL-12 and IL-2 used during the 5-day in vitro Th1 polarization are represented by triangles in
(B)–(E). The recipient mice received 53 104, 53 105, or 53 106 donor in vitro Th1-polarized C7 TCR-Tg CD4 T cells of each condition. Data are representative of
two experiments, one performed on day 16 and the other on day 19 post-infection.
(B) Frequency of donor C7 TCR-Tg CD4 T cells recovered from the recipient lung.
(C) Representative FACS plots of T-bet and KLRG1 expression after recovery of C7 TCR Tg CD4 T cells polarized with IL-2/IL-12 at 30 ng/mL in vitro. Each plot
represents the number of cells administered to the recipient. Summary graphs of the frequency of donor KLRG1+T-bethi donor C7 TCR Tg CD4 T cells at each
in vitro Th1 polarization condition and cell number administered are shown.
(D) Geometric MFI of T-bet in the KLRG1– donor C7 TCR Tg CD4 T cells at increasing in vitro polarization conditions and cell number administered.
(E) Representative FACS plots of expression of T-bet and either IFN-g or IL-17A of donor C7 TCR Tg CD4 T cells with IL-2/IL-12 at 30 ng/mL in vitro. Each plot
represents the number of cells administered to the recipient. Summary graphs of either IFN-g+ or IL-17A+ donor C7 TCR Tg CD4 T cells at each in vitro Th1
polarization condition and cell number administered are shown.
See also Figure S1.
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the number of cells injected but not the initial Th1-polarizing con-
ditions, even among CD4 T cells that did not upregulate KLRG1
(Figure 2D), indicating that a high degree of intraclonal competi-
tion for antigen dramatically suppressed T-bet expression,
regardless of the initial Th1-polarizing conditions. Moreover, the
intraclonal competition-induced downregulation of T-bet was
also associated with a decrease in IFN-g-producing cells and
an increase in IL-17A-producing cells in a dose-dependent
manner (Figure 2E). To test the possibility that the donor C7
CD4 T cells were competing for non-peptide factors, we
measured the percentage of terminally differentiated host-
derived effector CD4 T cells in the lungs of mice receiving
increasing doses of C7 TCR Tg CD4 T cells. We found no corre-
lation between the frequencies of donor C7 TCR Tg CD4 T cells
recovered from the lungs and the fraction of endogenous effec-
tors that were KLRG1+T-bet+++ (Figure S1). Collectively, these
data are most consistent with the conclusion that increased
levels of TCR stimulation drive higher fractions of the responding
T cells into the terminal effector state.Wecannot rule out the pos-
sibility that competition for factors other than specific peptide oc-
curs but only between CD4 T cells with the same TCR, but we
consider this scenario less likely. Interestingly, these data also
indicate that the Mtb-specific T cell response can be made to
switch froma Th1 into a Th17 responsewhen there are unphysio-
logically high numbers of T cells with identical TCRs.
IL-12/23p40 Promotes the Generation of Intravascular
Mtb-Specific CD4 T Cells
IL-12 drives the upregulation of T-bet expression in CD4 T cells
and is essential for expression of IFN-g and host resistance to
Mtb infection (Cooper et al., 1997; Flynn et al., 1995). IL-12, how-
ever, is also known topromote thegenerationof T cellswith similar
phenotypic properties as the intravascular effector cells that lack
protective capacity in Mtb infection. Therefore, we performed a
detailed examination of the contribution of IL-12/23p40 to the dif-
ferentiation of pulmonary Mtb-specific CD4 T cells by comparing
responses in infectedWT and p40/mice. On day 28 post-infec-
tion, we did not consistently observe differences in the number of
colony-forming units (CFUs) in the lungs of WT and p40/ mice
(presumably due to the early timepoint analyzed), but thebacterial
loads in the spleenwere reproducibly2 logs higher in the p40/
mice (Figures 3A and 3B). Consistent with previous results
(Cooper et al., 1997; Shafiani et al., 2013), Mtb-infected p40/
mice had an2- to 3-fold reduction in the frequency of I-AbESAT-
64–17-specific CD4 T cells compared to WT mice, confirming that
p40 plays an important role in the optimal expansion of effector
T cells inMtb infection (Figure 3C). When we examined themigra-
tion of T cells into the lungs using the intravascular stain at the time
of necropsy, we found an 2-fold reduction in the frequency of
iv+I-AbESAT-64–17-specific CD4 T cells in the p40
/ mice
compared to the WT, indicating that a larger fraction of the Mtb-
specific CD4 T cell response localized to the lung parenchyma in
the absence of p40 (Figure 3D).
The loss of iv+Mtb-specific CD4 T cells in the absence of p40
could be due to enhanced migration of T cells into the lungs or
loss of a subpopulation that does not migrate into the lungs,
such as the CX3CR1+KLRG1+ effector cells. We therefore next
performed a detailed analysis of T cell differentiation by staining
I-AbESAT-64–17-specific Foxp3
– effector CD4 T cells in WT
versus p40/ mice with a panel of differentiation markers
including CD73, CD69, CXCR3, KLRG1, CX3CR1, and CD103,
as well as the intravascular stain (Figure 3E). To examine the
poly-phenotype, we computed the fraction of the response
that expressed every possible combination of these seven
markers using SPICE. There was an overall increase in CD73+
Mtb-specific CD4 T cells and significant reduction in KLRG1+
and CX3CR1+ cells (Figures 3F, 3G, and S2A). In particular, there
was a near complete loss of effector cells with the non-protective
phenotype, iv+KLRG1+CX3CR1+. KLRG1 is induced by IL-12, so
the loss of the intravascular cells by this analysis could reflect the
lack of the KLRG1molecule rather than the terminal effector cells
themselves. However, by using an alternativemarker for terminal
effectors, we found that iv+CX3CR1+ cells were also nearly
completely absent from the p40/ mice (Figure 3H). There
was an overall reduction in T-bet expression in the p40/
compared to WT mice, but the hierarchy of T-bet expression
among the different subsets remained, with the terminally differ-
entiated iv+CX3CR1+ cells having the highest MFI for T-bet even
in the absence of p40 (Figure S2B). As expected, we also
observed a dramatic reduction in IFN-g production by antigen-
specific CD4 T cells (Figure S2C). IL-17A production by Ag-spe-
cific CD4 T cells was not observed in either the WT or p40/
mice, indicating that in the absence of p40 there is no immune
deviation into a Th17 response (Figure S2C).
Our poly-phenotypic analysis had shown that theMtb-specific
Th1 response is a complex mixture of multiple subpopulations
that can be discriminated with a set of markers that relate to
T cell differentiation state and localization to the lung vasculature
versus parenchyma. The approach used above in Figures 3E, 3F,
and S2A categorizes each cell in the population based on the
presence or absence of each analyte, but it does not take into
account the expression level of each defining molecule. More-
over, the data visualization does not directly compare the WT
and p40/ Mtb-specific populations. To more carefully charac-
terize the impact of IL-12/23p40 on the diversity of differentiation
states present within the pulmonary population of Mtb-specific
CD4 T cells, we performed a t-Distributed Stochastic Neighbor
Embedding (tSNE) analysis on a panel including seven pheno-
typic markers and the iv stain. tSNE is amachine learning dimen-
sionality-reducing algorithm that compares similarities of data
points in high dimensional space and plots the data in two di-
mensions in a way that preserves the structure of the dataset.
Cells that are similar in (in the case of this particular panel)
eight-dimensional space cluster close to each other on a 2D
scatterplot. In this analysis, cells were stained with the same
panel as in Figures 3E, 3F, and S2A with the addition of the
transcription factor TCF-1. After gating on Foxp3–CD44highI-
AbESAT-64–17 tetramer
+ CD4 T cells, Ag-specific T cells from
WT and p40/mice were electronically concatenated into a sin-
gle file for tSNE analysis so that the WT and knockout (KO) cells
were directly compared and clustered against each other.
We observed that there was only limited overlap of subsets of
Ag-specific CD4 T cells present in the WT versus p40/ mice
(Figures 3H and 3I). By gating on cells positive for each individual
marker and then overlaying those events on top of the tSNE
plots, we can see the contribution of each of the markers to
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the overall structure of the population (Figure 3I). For example,
the intravascular stain was responsible for a major division in
the overall populations of WT and p40/ cells, and the
increased expression of CD73 in p40/ mice created the sepa-
ration between parenchymal cells in the WT versus KO cells.
Collectively, these data show that theMtb-specific Th1 response
comprises cells in several distinct differentiation states, and the
Th1-polarizing cytokine IL-12/23p40 has a major role in shaping
the response, beyond simply inducing IFN-g production. Unex-
pectedly, p40 drives the accumulation of a prominent population
of lung blood intravascular effector cells, which is not protective
in the setting of Mtb infection.
T-Cell-Intrinsic T-Bet Is Required for Host Survival but
Also Drives Th1 Cell Differentiation into Non-protective
Intravascular Cells
Mtb-infected T-bet-deficient mice succumb early compared to






Figure 3. IL-12/23p40 Drives the Generation of Intravascular CD4+ T Cells during Mtb Infection
WT and p40/ mice infected with Mtb by aerosol infection. On day 28PI, lungs and spleen were harvested.
(A and B) Log10-transformed CFU counts of (A) lung and (B) spleen in WT and p40
/ mice. The dotted line represents the limit of detection. Data are repre-
sentative of two experiments. ****p % 0.0001, unpaired two-tailed t test.
(C) Representative FACS plots of lung I-AbESAT-64–17
+CD4+ T cells in WT and p40/ mice. Summary graph of the frequency of I-AbESAT-64–17
+CD4+ T cells in
WT and p40/ mice is shown. Data are pooled from two experiments. ****p % 0.0001, unpaired two-tailed t test.
(D) Summary graph of the frequency of iv+ I-AbESAT-64–17
+CD4+ T cells in WT and p40/mice. Data are pooled from two experiments. ****p% 0.0001, unpaired
two-tailed t test.
(E) Representative FACS plots of CD73, CD69, CXCR3, KLRG1, CX3CR1, and CD103 expression on iv– and iv+ I-AbESAT-64–17
+CD4+ T cells in the lung.
(F) SPICE analysis of WT and p40/ I-AbESAT-64–17
+CD4+ T cells from the lung. Pie graphs depict the distribution of the different combinations of receptor
expression. Arcs represent the expression pattern of receptors on intravascular (red) or CD73+ (green) cells. See also Figure S2A.
(G) Summary graph of the frequency of lung iv+CX3CR1+I-AbESAT-64–17
+CD4+ T cells in WT and p40/ mice. Results are pooled from two experiments.
****p % 0.0001, unpaired two-tailed t test.
(H) tSNE map of overlay of lung I-AbESAT-64–17
+CD4+ T cells clusters in WT and p40/ mice.
(I) tSNE map of CD45iv, CX3CR1, KLRG1, CXCR3, CD69, CD73, TCF-1, and CD103 of the lung I-AbESAT-64–17
+CD4+ T cells clusters in WT and p40/ mice.
Circles are drawn to highlight cell populations discussed in the text.
See also Figures S2B and S2C.
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T cells (Sullivan et al., 2005). However, in other model systems
T-bet has also been shown to drive the differentiation of
KLRG1+CXCR3– T cells, so we next evaluated the role of T-bet
in the differentiation of Mtb-specific effector CD4 T cells. Similar
to the p40/ mice, at day 28 post-infection we did not routinely
observe an increase in pulmonary bacterial loads, but the num-
ber of CFUs in the spleen was 1 log increased in the T-bet/
mice compared to WT mice at this time point (Figures 4A and
4B). Unlike the p40/ mice, T-bet/ mice had an I-AbESAT-
64–17-specific CD4 T cell response of similar magnitude to that
seen in WT mice (Figure 4C). However, there was a dramatic
reduction in the fraction of intravascular I-AbESAT-64–17-specific
CD4 T cells in the T-bet/ mice (Figure 4D). In the absence
of T-bet, there was a decrease in Ly6C and near total lack of
KLRG1 expression on Ag-specific T cells, but a striking increase
in parenchymal CD69+CD103+ CD4 T cells (Figures 4E, 4F, and
S3). tSNE analysis on I-AbESAT-64–17-specific CD4 T cells (using
the same T cell differentiation panel excluding KLRG1 as in Fig-
ure 3) showed that there was almost no overlap between the
clusters of effector cell subsets present in WT and T-bet/
mice (Figures 4G and 4H). Much of the difference in WT and
T-bet/CD4 T cells was accounted for by a loss of the intravas-
cular population and a gain in the CD69+CD103+ population,
which are markers used to identify tissue resident effector mem-
ory (Trm) cells (Figure 4H) (Schenkel et al., 2014). Therefore, in
Mtb infection T-bet expression drives CD4 T cells into highly
differentiated intravascular effector cells and inhibits the accu-
mulation of T cells with a Trm-like phenotype.
We next asked whether host susceptibility and the effect on
T cell differentiation were due to T-cell-intrinsic T-bet expres-
sion. First, we infected WT, T-bet/, and mice with a selective
ablation of T-bet in T cells (T-betfl/fl-CD4CRE+) and monitored
the time to moribundity. T-betfl/fl-CD4CRE+ mice displayed a
very similar survival compared to intact T-bet/ mice, suggest-
ing that T-cell-intrinsic T-bet is responsible for the vast majority
of host protection (Figure 5A). To analyze the role of T-cell-
intrinsic T-bet in the generation of the intravascular effector
T cells, we sorted with FACS naive congenically disparate WT
and T-bet/ polyclonal CD4 T cells from uninfectedmice, mixed
them together in equal numbers, and transferred them into Mtb-
infected, WT recipient mice (Figure 5B) (Sakai et al., 2016). The
donor cells were then analyzed on day 28 post-infection. Among
the T-bet/ donor cells, there was a 2.5-fold reduction in the
fraction of the expanded CD44highFoxp3– effector CD4 T cells
that were in the vasculature of the lung (Figure 5C). Additionally,
there was a complete lack of KLRG1+ and CX3CR1+ CD4 T cells
and an 3-fold increase in CD69+ parenchymal cells in the
T-bet/ donors compared to the WT (Figure 5C). Therefore,
T-cell-intrinsic T-bet, rather than T-bet expression in other im-
mune cell types, is responsible for both host protection and
also the generation of the intravascular effector cells.
T-Bet Prevents ImmuneDeviation into Th17Cells during
Mtb Infection
The antagonistic relationship between T-bet and RORgt-medi-
ated T cell differentiation has been demonstrated previously in
other models (Lazarevic et al., 2011), so we next examined the
role of T-bet in regulating Th1 versus Th17 responses in Mtb
infection. There was a complete switch in the cytokine produc-
tion following restimulation with ESAT-61–20 peptide from IFN-g
into IL-17A production in the T-bet/ mice (Figures 6A and
6B). The increase in IL-17A-producing cells could result from
either the expansion of a small population of Th17 cells normally
found in WT mice or the diversion of Th1 cells into Th17 cells in
the absence of T-bet. To discriminate between these two possi-
bilities, we infected T-bet/-T-bet ZsGreen reporter mice and
measured IFN-g and IL-17A by direct ex vivo staining. Strikingly,
all of the I-AbESAT-64–17-specific CD4 T cells in the WT and
T-bet/ mice were T-bet reporter positive, and 50% of
T-bet/ Ag-specific CD4 T cells were IL-17A+ in the direct
ex vivo assay (Figure 6C). As expected, there was a large reduc-
tion in IFN-g production by T-bet/ cells and minimal IL-17A
detected in the WT CD4 T cells. In addition to the increased IL-
17A production, 75% of the T-bet/ I-AbESAT-64–17-specific
ZsGreen+ CD4 T cells co-expressed RORgt compared to <2%
of the WT (Figure 6D). Therefore, in the absence of T-bet
would-be Th1 cells upregulate RORgt and differentiate into
potent IL-17A-producing cells. We next performed a tSNE anal-
ysis on concatenated WT and T-bet/ tetramer+ lung CD4
T cells using a seven-dimensional panel including RORgt, iv
stain, CD69, CD103, CD73, CXCR3, and CX3CR1. As found in
Figure 4, WT and T-bet/ T cells largely clustered separately,
but the cells at the interface between WT and KO (representing
the cells that were similar between the two) were all negative
for RORgt, emphasizing that RORgt expression in the T-bet/
cells is associated with a T cell differentiation state that is dras-
tically altered compared to WT cells (Figure 6E). Therefore, in
contrast to IL-12/23p40, T-bet suppresses the expression of
RORgt, thereby ensuring Th1 lineage identity in Mtb infection.
The role of IL-17A in Mtb infection is context dependent, as it
can be protective (Gopal et al., 2014), pathogenic (Cruz et al.,
2010), or relatively inconsequential (Khader et al., 2011) depend-
ing on the setting. To test the impact of the Th17 response gener-
ated in Mtb-infected T-bet/ mice on host resistance, WT and
KO mice were treated with aIL-17A blocking antibody either at
the peak or a week prior to the peak of the T cell response. In
two independent experiments, IL-17 blockade had no effect on
the survival of WT mice, but there was a minor trend for early
mortality in the treated T-bet/ mice (Figure 6F), indicating
that the large Th17 response in the T-bet/ mice is unlikely to
be pathogenic and may have a minor role in protection. There-
fore, although T-bet promotes the generation of non-protective
intravascular effectors against pulmonary Mtb infection, it is
essential to drive IFN-g production and prevent the reciprocal
polarization of T cells into weakly protective Th17 cells.
CD4 T-Cell-Derived IFN-g Inhibits the Accumulation of
Intravascular, Terminally Differentiated Mtb-Specific
Effector CD4 T Cells in a Dose-Dependent Manner
Last, we examined the role of the defining Th1 cytokine, IFN-g,
on the differentiation of Mtb-specific CD4 T cells. As expected,
on day 28 post-infection IFN-g/ mice had 10-fold more
CFUs in the lung and 500-fold more CFUs in the spleen
compared to WT mice (Figures 7A and 7B). The frequency of
I-AbESAT-64–17-specific CD4 T cells was similar in WT and
IFN-g/ mice, but there was a dramatic increase in the fraction
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of the response localized to the vasculature in the IFN-g/ mice
(Figures 7C–7E). Phenotypic analysis showed that the expan-
sion of intravascular I-AbESAT-64–17-specific CD4 T cells in the
IFN-g/ mice was primarily due to an increase in CX3CR1+
KLRG1+ terminal effector phenotype cells (Figures 7F, 7G, and
S4A). Interestingly, in WTmice T cell factor 1 (TCF-1, also known
as transcription factor 7, T cell specific, TCF7) expression is de-






Figure 4. T-Bet Is Essential for the Differentiation of Intravascular Th1 Cells and Inhibits the Development of CD69+CD103+ Parenchymal
CD4 T Cells
WT and T-bet/ mice infected with Mtb by aerosol infection. On day 28PI, lungs and spleen were harvested.
(A and B) Log10-transformedCFU counts of (A) lung and (B) spleen inWT and T-bet
/mice. The dotted line represents the limit of detection. Data are pooled from
two experiments. ****p % 0.0001, unpaired two-tailed t test.
(C) Representative FACS plots of lung I-AbESAT-64–17 versus CD45iv CD4 T cells from WT and T-bet
/ mice. Summary graph of the frequency of I-AbESAT-
64–17
+CD4+ T cells from WT and T-bet/ mice is shown. Data are pooled from three experiments.
(D) Summary graphs of frequency of iv+I-AbESAT-64–17
+CD4+ T cells from WT and T-bet/ mice. Data are pooled from three experiments. ****p % 0.0001,
unpaired two-tailed t test.
(E) Representative FACS plots of CD69, CD103, KLRG1, and Ly6C versus CD45iv on I-AbESAT-64–17
+CD4+ T cells in the lung from WT and T-bet/ mice.
(F) SPICE analysis of WT and T-bet/ I-AbESAT-64–17
+CD4+ T cells from D28PI lung. Pie graphs depict the distribution of the different combinations of receptor
expression. See also Figure S3.
(G) tSNE map of overlay of lung I-AbESAT-64–17
+CD4+ T cells clusters in WT and T-bet/ mice.
(H) tSNE map of CD45iv, CX3CR1, CXCR3, CD69, CD73, TCF-1, and CD103 of the lung I-AbESAT-64–17
+CD4+ T cells clusters in WT and T-bet/ mice. Circles
are drawn to highlight cell populations discussed in the text.
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expansion of iv+ cells in the IFN-g/micewas specifically due to
an increase in the TCF-1 negative fraction of these cells. TCF-1 is
high in naive cells, and maintenance of its expression in effector
cells has been associated with T cells in a less differentiated
state (Tiemessen et al., 2014). Therefore, in the absence of
IFN-g, the increase in the localization of effector CD4 T cells in
the lung blood vasculature is largely due to the increase in a
highly polarized subset of CX3CR1+KLRG1+CXCR3–TCF-1– ter-
minal effector cells. The MFI of T-bet staining in the terminally
differentiated cells was comparable in the WT and IFN-g/
cells, 4,000 and 3,500, respectively, indicating that the accumu-
lation of terminal effectors was not due to enhanced T-bet
expression in the absence of IFN-g (Figure S4B). Eight-dimen-
sional tSNE analysis showed that there was a high degree of
overlap between the various effector cell differentiation sub-
states present in the WT and IFN-g/ mice (Figures 7H and
7I). Therefore, in contrast to IL-12/23p40 and T-bet, IFN-g has
much less of an impact on the structure of the Th1 population.
In terms of T cell differentiation during Mtb infection, IFN-g pri-
marily prevents the increased accumulation of the non-protec-
tive intravascular effector cells, perhaps acting in a negative
feedback loop opposing the effects of IL-12/23p40 and T-bet.
Last, we askedwhether the CD4 T-cell-derived IFN-gwas able
to impact the differentiation of CD4 T cells. We transferred
increasing numbers of bulk WT or IFN-g/ CD4 T cells isolated
from uninfected mice into day 7 infected RAG1/ mice. On day
42 post-infection, we examined the generation of intravascular
KLRG1+ donor CD4 T cells. This allowed us to examine the
impact of the number of transferred CD4 T cells as well as their
production of IFN-g on the development of terminally differenti-
ated intravascular effector cells. Interestingly, for both WT and
IFN-g/ CD4 T cells there was a positive relationship between
the number of donor cells injected and the fraction of cells that
became iv+KLRG1+ cells. This may indicate that a yet-unidenti-
fied T-cell-derived factor distinct from IFN-g (e.g., IL-2) promotes
the generation of terminal effectors (Figure 7J). However, at each
dose of donor cells, IFN-g/CD4T cells generated3- to 4-fold
more iv+KLRG1+ cells compared to WT donors, indicating that
T-cell-derived IFN-g can limit the generation of T cells with an
intravascular effector phenotype. Then we tested whether
increased production of IFN-g by CD4 T cells would have the
opposite effect observed in the KO, which lead to decreased
intravascular effectors. To do so, we utilized ARE-Del CD4
T cells that have a deletion in a 30 regulatory element in the
IFN-g mRNA that stabilizes the transcript, thereby leading to
enhanced IFN-g production (Hodge et al., 2014). CD45.1+ WT
and CD45.2+ ARE-DEL CD4 T cells from uninfected donor
mice were mixed together and transferred into day 7 infected
TCRa/ recipients. On day 60 post-infection, the percentage
of iv+KLRG1+ WT or ARE-DEL CD4 T cells was determined.
The ARE-DEL CD4 T cells displayed an 2-fold reduction in
the fraction of cells developing into iv+KLRG1+ effector cells (Fig-
ure 7K). Overall, these data indicate that CD4 T-cell-derived
IFN-g has a dose-dependent effect in limiting the accumulation
of intravascular effector cells in Mtb infection.
DISCUSSION
To characterize the protective capacity of various subsets of
Th1 cells, we and others have purified CD4 T cells based on
either parenchymal versus intravascular localization (Sakai
et al., 2014, 2016) or KLRG1 versus PD-1 expression (Moguche
et al., 2015). Both approaches have found that Th1 cells with a
less-differentiated phenotype are more protective against Mtb
infection. Here, we further refine this approach by sorting four
subsets of Mtb-specific T cells based on both KLRG1 and iv
stain and examining the protective capacity of each population.
In general, we find that only the iv+KLRG1+ CD4 T cells were
incapable of control of Mtb. Each of the other subsets displayed
the ability to expand, migrate into the lungs, and reduce bacterial
burdens. Interestingly, KLRG1 alone was not a good predictor of
protective capacity, as KLRG1+ CD4 T cells isolated from the
parenchymal were highly protective. In fact, we found that
iv–KLRG1+ CD4 T cells expanded less compared to iv–KLRG1–
cells but displayed similar levels of protection, indicating that
parenchymal KLRG1+ CD4 T cell may provide more protection
on a per-cell basis compared to the KLRG1– CD4 T cells.
Recently, it was shown that KLRG1+ CD4 T cells preferentially
A B C
Figure 5. T-Cell-Intrinsic T-Bet in Host Protection and CD4 T Cell Differentiation during Mtb Infection
(A) A survival curve for WT, T-bet/, and T-betfl/fl CD4-Cre mice after aerosol Mtb infection. ****p % 0.0001, log-rank test.
(B) Experimental schematic of naive adoptive transfer of sortedWT and T-bet/ cells into D9PI recipients and harvested on D28PI. Representative FACS plots of
donor cell isolation from recipient lung on D28PI are shown.
(C) Representative concatenated FACS plots of KLRG1, CX3CR1, and CD69 versus CD45iv on WT and T-bet/ donor cells from three recipient mice. Data are
representative of two experiments.
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localize with lung macrophages, and PD-1+ CD4 T cells, here
identified as iv–KLRG1– CD4 T cells, localize in lung B cell areas
(Torrado et al., 2015), so it is possible that the difference between
KLRG1+ and KLRG1– parenchymal cells may be due to their abil-
ity to interact with infected macrophages.
It is not clear what role CX3CR1+KLRG1+ intravascular
effector cells play in the control of Mtb infection. Although our
data indicate that this type of Th1 cell is unable to provide protec-
tion during Mtb infection, we should point out a caveat that our
experiments were performed by transfer of purified populations
of effector CD4 T cells into infected T cell-deficient hosts. Given
that the CX3CR1+KLRG1+ intravascular Th1 cells do not expand
well, it is possible that these cells may have some contribution to






Figure 6. T-Bet Inhibits RORgt Expression
and Prevents Deviation of Th1 Cells into
Th17 Cells during Mtb Infection
(A and B) Lung lymphocytes stimulated with ESAT-
61–20 peptide and cytokine expression measured
by intracellular cytokine staining. (A) Representa-
tive FACS plots of TNF, IFN-g, and IL-17A expres-
sion in iv– CD4 T cells in WT and T-bet/ mice. (B)
Summary graphs of frequency of IFN-g+ and IL-
17A+ CD44hiFoxp3–CD4+ T cells are shown. **p %
0.01, ****p % 0.0001, unpaired two-tailed t test.
Data are representative of three experiments.
(C) Representative FACS plots of direct ex vivo
IFN-g, TNF, and IL-17A expression in iv– lung
effector CD4 T cells from T-bet ZsGreen reporter
and T-bet/ T-bet ZsGreen reporter mice on
D28PI.
(D) Representative FACS plots of RORgt expres-
sion in iv– lung effector CD4 T cells from T-bet
ZsGreen reporter and T-bet/ T-bet ZsGreen re-
porter mice on D28PI.
(E) tSNE map of overlay of lung I-AbESAT-
64–17
+CD4+ T cells clusters in WT, T-bet/, and all
RORgt+ cells.
(F) Two independent survival curves of WT and
T-bet/ mice treated with anti-IL-17A. Gray box
indicates the time of treatment.
cular Th1 are replenished from a source
of less-differentiated T cells. We have
previously shown that high levels of
IFN-g production selectively benefit con-
trol of Mtb infection in the spleen (Sakai
et al., 2016), so it is possible that
CX3CR1+KLRG1+ Th1 cells that produce
high levels of IFN-g have a role in control
of extrapulmonary Mtb infection. Consis-
tent with this hypothesis, we found
greater defects in bacterial control in
the spleens of p40/, T-bet/, and
IFN-g/ mice compared to WT mice,
but this hypothesis has not yet been
formally tested. We should also point out
that these results do not show that termi-
nal differentiation of CD4 T cells impairs
control of Mtb infection. However, it was recently shown that
T-bet+/ mice display slightly reduced bacterial loads over the
first 2 months of infection (Torrado et al., 2015), and our prelim-
inary results show that Tbet+/ mice live much longer following
Mtb infection compared toWTmice (data not shown). Therefore,
it is possible that terminal differentiation not only generates
T cells that cannot control pulmonary Mtb infection, but also
impairs control of the infection at the level of the host.
Given the major role for IL-12 and T-bet in the generation of
terminal effector T cells, we speculated that the p40/T-bet axis
may have an unappreciated detrimental effect on the protective
capacity of some Mtb-specific CD4 T cells that is normally
masked by their major role in host-protective IFN-g production.
Indeed, p40 and T-bet were required for the generation of
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Figure 7. CD4 T-Cell-Derived IFN-g Limits the Accumulation of Intravascular Terminal Effector Th1 Cells during Mtb Infection
WT and IFN-g/ mice infected with Mtb by aerosol infection. On day 28PI, lungs and spleen were harvested. Data are pooled from two experiments.
(A and B) Log10-transformed CFU counts of (A) lung and (B) spleen in WT and IFN-g
/ mice. The dotted line represents the limit of detection. ****p % 0.0001,
unpaired two-tailed t test.
(C) Representative FACS plot and histograms of CD45iv staining of I-AbESAT-64–17
+CD4+ T cells from the lungs of WT and IFN-g/ mice.
(D) Summary graph of two experiments of the frequency of I-AbESAT-64–17
+CD4+ T cells from the lungs of WT and IFN-g/ mice.
(E) Summary graph of the frequency of iv+I-AbESAT-64–17
+CD4+ T cells from the lungs of WT and IFN-g/ mice. ***p % 0.001, unpaired two-tailed t test.
(F) Representative FACS plots of CX3CR1, KLRG1, CXCR3, CD69, CD103, CD73, and TCF-1 versus CD45iv on lung I-AbESAT-64–17
+CD4+ T cells from WT and
IFN-g/ mice.
(G) SPICE analysis of WT and IFN-g/ lung I-AbESAT-64–17
+CD4+ T cells. Pie graphs depict the distribution of the different combinations of receptor expression.
See also Figure S4A.
(H) tSNE map of overlay of lung I-AbESAT-64–17
+CD4+ T cells clusters in WT and IFN-g/ mice.
(I) tSNE map of CD45iv, CX3CR1, CXCR3, CD69, CD73, TCF-1, and CD103 of the lung I-AbESAT-64–17
+CD4+ T cells clusters in WT and IFN-g/ mice.
(legend continued on next page)
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iv+KLRG1+ terminal effector Th1 cells in Mtb infection. More-
over, in T-bet/ mice we observed a dramatic increase in
CD69+CD103+ parenchymal CD4 T cells, indicating that T-bet
may repress the development of effector CD4 T cells with a
tissue-resident memory-like phenotype. Although we cannot
formally conclude that the iv–CD69+CD103+ CD4 T cells we
observed in the absence of T-bet were truly non-recirculating tis-
sue residents (as the parabiosis experiments typically done to
establish residency cannot readily be performed in chronic infec-
tions), it was recently shown that T-bet overexpression prevents
the development of skin tissue resident memory CD8 T cells in
the setting of acute herpes simplex virus infection (Mackay
et al., 2015). Together our data indicate that T-bet is dispensable
for T cell migration into the lungs, T-bet drives T cells to differen-
tiate into a state in which they cannot migrate into the lungs, and
that T-bet prevents the generation of T cells resembling tissue-
resident cells in the lungs. From this perspective, it could be
argued that T-bet is not needed for lung CD4 T cell responses
and even opposes the accumulation of pulmonary CD4 T cells
at several levels.
Previously, it was shown that in the absence of T-bet IL-10 re-
sponses were increased in Mtb infection (Sullivan et al., 2005).
Here, we find dramatic increases in Th17 responses in Mtb-
infected T-bet/ mice. In fact, we find that T-bet/ Mtb-spe-
cific Th17 cells report T-bet promoter activity, indicating that
Th1 cells upregulate RORgt and become IL-17A-producing cells
in the absence of T-bet. T-bet antagonizes RORgt, the lineage-
defining transcription factor of Th17 cells, so in the absence
of T-bet the Th17 response was anticipated (Lazarevic et al.,
2011). On the other hand, switching to a Th17 response is not
always observed in the absence of T-bet, as T-bet/ CD4
T cells mount Th2 responses in T. gondii-infected mice (Zhu
et al., 2012). Therefore, although Th17 responses are not often
observed in Mtb infection, all of the key factors for the induction
of Th17 cells may be present, but T-bet actively represses the
development of RORgt+ Th17 CD4 T cells. In fact, we found
that the intraclonal competition that results from simply injecting
high numbers of C7 TCR Tg CD4 T cells leads to the downregu-
lation of T-bet and development of Th17 TCR Tg CD4 T cells.
Although our data failed to find amajor role for IL-17A in host pro-
tection, Th17 cells have been shown to be important for protec-
tion in the setting of infection with hypervirulent isolates of Mtb
(Freches et al., 2013; Gopal et al., 2014; Khader et al., 2007).
It is possible that T-bet may be weakly induced or even sup-
pressed in Mtb-specific CD4 T cells during infection with more
virulent Mtb isolates such as Beijing strains compared to less
virulent bacteria such as H37Rv studied here.
Although, the overall impact of IFN-g on T cell differentiation
was much less compared to p40 and T-bet, we observed a large
increase in effector CD4 T cells in Mtb-infected IFN-g/ mice,
as has been previously reported (Dalton et al., 2000). However,
we did find that CD4 T-cell-derived IFN-g limits the accumulation
of terminally differentiated intravascular effectors in a dose-
dependent manner, in complete contrast to the role of p40 and
T-bet in promoting this cell type. It is not clear how IFN-g limits
the accumulation of intravascular effectors, but it may act
directly on Mtb-specific CD4 T cells to induce apoptosis (Li
et al., 2007) through inducible nitric oxide synthase (iNOS)-
dependent death of T cells (Dalton et al., 2000), the inhibition
of T cells through the induction of indoleamine 2,3-dioxygenase
(IDO), or simply the increased disease burden. Regardless, it is
interesting to note that the major cytokine product of Th1 cells
may act in a negative feedback loop to inhibit the accumulation
of the most polarized Th1 cells.
It is not known, however, whether human CD4 T cells adopt an
intravascular terminally differentiated phenotype in Mtb infec-
tion, but our results indicate it may be important to examine
not only how various new Mtb vaccine candidates drive large
expansion of IFN-g-producing CD4 T cells, but also how they
impact the differentiation state of Mtb-specific CD4 T cells. For
example, viral vector-based approaches, in particular, may
lead to high levels of terminally differentiated T cells or memory
T cells that are prone to terminal differentiation after recall.
Collectively, our data show that, while some induction of p40/
T-bet-dependent CD4 T cell polarization is required for host
resistance to Mtb, this must be properly balanced as this
pathway can negatively impact protective capacity of Mtb-spe-
cific CD4 T cells.
EXPERIMENTAL PROCEDURES
Mice
All strains and sources of mice are found in Supplemental Experimental Pro-
cedures. All animals were housed at the Association for the Assessment and
Accreditation of Laboratory Animal Care-approved facility at the National Insti-
tute of Allergy and Infectious Diseases (NIAID) according to the National
Research Council Guide for the Care andUse of Laboratory Animals. All exper-
iments involving the use of animals were approved by the NIAID Animal Care
and Use Committee.
Aerosol Mtb Infection, Intravascular Staining, and Lung Lymphocyte
Isolation
The aerosol infection, iv staining, and lung lymphocyte isolation were per-
formed as previously described (Sakai et al., 2016). Detailed methods are
found in Supplemental Experimental Procedures.
In Vitro Stimulation, FlowCytometry, Cell Sorting, In Vitro CD4 TCell
Polarization, and Adoptive Transfer Experiments
In vitro T cell stimulation and flow cytometry were performed as previously
described (Sakai et al., 2016). All antibodies used for flow cytometry can be
found in Supplemental Experimental Procedures. For cell sorting, effector
CD4 T cells were isolated from the lungs of Foxp3-EGFPmice and were sorted
into four populations: KLRG1–CD45dim, KLRG1–CD45+, KLRG1+CD45dim,
and KLRG1+CD45+. For protection adoptive transfer (ADT) experiments, the
same number of cells from each population was adoptively transferred into
TCRa/ recipients. Lungs were harvested from recipient mice on day 28
post-infection (PI). For conversion ADT experiments, cells were transferred
(J) Summary graph of the frequency of donor WT or IFN-g/ KLRG1+iv+CD4 T cells with increasing numbers of T cells transferred. **p % 0.01, unpaired two-
tailed t test.
(K) Representative FACS plot of donor cell recovery from recipient lung. Summary graph of the frequency of donorWT and ARE-KLRG1+ intravascular CD4 T cells
is shown. **p % 0.01, paired two-tailed t test.
See also Figure S4B.
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to infection-matched congenically disparate recipient mice. Lungs were har-
vested from recipient mice on day 42PI. For migration ADT experiments,
sorted naive cells were transferred into congenically disparate recipient mice
1.5 days prior to harvest. For the clonal competition ADT experiment, C7
TCR Tg CD4 T cells were in vitro polarized under Th1 conditions and then
transferred into congenically disparate recipient mice day 6PI. Lungswere har-
vested from recipient mice on day 16PI. Detailedmethods are found in Supple-
mental Experimental Procedures.
Tetramer Pull-Down Assay
The tetramer pull-down was performed as previously described (Hataye et al.,
2006). Detailed methods are found in Supplemental Experimental Procedures.
Statistical Analysis
All statistical analysis was performed in Prism (GraphPad). An unpaired two-
tailed t test, paired t test, one-way ANOVA with Tukey’s multiple comparisons,
and log-rank tests were used in the analysis.
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